Brind.

Analyst firms, including Cantor Fitzgerald and Morgan Stanley, raised price objectives on CVS Health shares.

4 reports, 2 independent Updated Sep 3
Gone quiet
Reports
4
Developments
1
Repetition
75%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Analyst firms, including Cantor Fitzgerald and Morgan Stanley, raised price objectives on CVS Health shares.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story